Henry Schein Inc (FRA:HS2)
€ 64.18 -2.8 (-4.18%) Market Cap: 7.85 Bil Enterprise Value: 10.51 Bil PE Ratio: 27.87 PB Ratio: 2.43 GF Score: 83/100

Henry Schein Inc at Nasdaq Investor Conference Transcript

Dec 04, 2019 / 08:45AM GMT
Release Date Price: €61.93 (-0.24%)
Unidentified Analyst

Okay. Good morning, everyone. Mic on now? There it is. Okay. Good. Welcome to session #2. Glad to have you here for Day 2. And we have our great friends from Henry Schein back, Steve Paladino, who's the CFO of Henry Schein. And we're going to -- Steve, we're going to get right into it, okay?

Steven Paladino
Henry Schein, Inc. - Executive VP, CFO & Executive Director

Good.

Questions & Answers

Unidentified Analyst

So it was an interesting year for you. There were some divestitures, strategic developments at Henry Schein over the last year, spun off the Animal Health business as well as the formation of Henry Schein One. So maybe you could talk everyone through that and what the long-term opportunities, thoughts were around both of those transactions and the growth prospects for obviously Medical and Dental.

Steven Paladino
Henry Schein, Inc. - Executive VP, CFO & Executive Director

Sure thing. Well, thank you for having us. It's a pleasure to be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot